跳至主要内容
临床试验/NCT05258435
NCT05258435进行中(未招募)不适用

Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc

NuVasive10 个研究点 分布在 1 个国家目标入组 131 人开始时间: 2022年2月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
131
试验地点
10
主要终点
Clinical Composite Success

研究概览

简要总结

A prospective, multicenter post-market clinical follow-up study to evaluate the 10-year long-term safety and effectiveness of the Simplify Disc in subjects who were enrolled in the post approval study (NCT04630626).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subject was enrolled in the Simplify Disc post approval study (NCT04630626) at a participating study site
  • Subject understands the conditions of enrollment and is willing to sign an informed consent form to participate in the study

排除标准

  • Subject had an SSI at the index level during the post approval study (NCT04630626)
  • Subject was withdrawn or withdrew consent to participate in the post approval study (NCT04630626)

结局指标

主要结局

Clinical Composite Success

时间窗: 10 years

Individual patient success for the primary endpoint will be assessed at 120 months and is defined as follows: 1. Improvement on the Neck Disability Index (NDI) of at least 15 percentage points compared to baseline (pre-op), and 2. No device failures by month 120, and 3. No secondary surgical intervention (SSI) at the index level (i.e., revision, removal, reoperation, or supplemental fixation) by month 120.

次要结局

  • Sensory status at each annual timepoint compared to baseline(10 years)
  • Displacement or migration of the Simplify Disc at each annual timepoint will be compared to the post-op timepoint in the IDE study (NCT02667067)(10 years)
  • Motor status at each annual timepoint compared to baseline(10 years)
  • Treatment satisfaction questionnaire at each annual timepoint(10 years)
  • Percentage of subjects meeting the minimal clinically important difference (MCID) for NDI at each annual timepoint(10 years)
  • Disc height at each annual timepoint will be compared to baseline(10 years)
  • Percentage of subjects meeting MCID for Visual Analog Scale (VAS) for each of the following pain locations and each annual timepoint: neck and arm pain, neck only pain, left arm pain, and right arm pain(10 years)
  • Dysphagia Handicap Index1 (DHI) at each annual timepoint compared to baseline(10 years)
  • Adjacent level disc degeneration (ALDD) at each annual timepoint will be compared to baseline(10 years)
  • Rate of adverse events attributable to Simplify Disc, or use of additional NuVasive instruments, implants, or technologies at each annual timepoint(10 years)
  • Range of motion (ROM) at each annual timepoint compared to baseline(10 years)
  • SF-12v2® Health Survey at each annual timepoint compared to baseline(10 years)

研究者

发起方
NuVasive
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验